Literature DB >> 26956187

Skeletal inflammation and attenuation of Wnt signaling, Wnt ligand expression, and bone formation in atherosclerotic ApoE-null mice.

Yu Liu1, Maria Almeida1, Robert S Weinstein1, Charles A O'Brien1, Stavros C Manolagas1, Robert L Jilka2.   

Abstract

ApoE-null (ApoE-KO) mice fed a high-fat diet (HFD) develop atherosclerosis, due in part to activation of vascular inflammation by oxidized low-density lipoprotein. Since bone loss also occurs in these mice, we used them to investigate the impact of oxidized lipids on bone homeostasis and to search for underlying pathogenic pathways. Four-month-old female ApoE-KO mice fed a HFD for three months exhibited increased levels of oxidized lipids in bone, as well as decreased femoral and vertebral trabecular and cortical bone mass, compared with ApoE-KO mice on normal diet. Despite HFD-induced increase in expression of Alox15, a lipoxygenase that oxidizes LDL and promotes atherogenesis, global deletion of this gene failed to ameliorate the skeletal impact of HFD. Osteoblast number and function were dramatically reduced in trabecular and cortical bone of HFD-fed mice, whereas osteoclast number was modestly reduced only in trabecular bone, indicating that an imbalance in favor of osteoclasts was responsible for HFD-induced bone loss. These changes were associated with decreased osteoblast progenitors and increased monocyte/macrophages in the bone marrow as well as increased expression of IL-1β, IL-6, and TNF. HFD also attenuated Wnt signaling as evidenced by reduced expression of Wnt target genes, and it decreased expression of pro-osteoblastogenic Wnt ligands. These results suggest that oxidized lipids decrease bone mass by increasing anti-osteoblastogenic inflammatory cytokines and decreasing pro-osteoblastogenic Wnt ligands.

Entities:  

Keywords:  Wnt signaling; bone remodeling; inflammation; osteoblasts; osteoclasts; osteoporosis

Mesh:

Substances:

Year:  2016        PMID: 26956187      PMCID: PMC6415649          DOI: 10.1152/ajpendo.00501.2015

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  13 in total

Review 1.  Low-Density Lipoprotein Receptor-Related Proteins in Skeletal Development and Disease.

Authors:  Tao Yang; Bart O Williams
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

2.  The Quest for Osteoporosis Mechanisms and Rational Therapies: How Far We've Come, How Much Further We Need to Go.

Authors:  Stavros C Manolagas
Journal:  J Bone Miner Res       Date:  2018-02-22       Impact factor: 6.741

Review 3.  Atherosclerosis and multi-organ-associated pathologies.

Authors:  W Coles Keeter; Shelby Ma; Natalie Stahr; Alina K Moriarty; Elena V Galkina
Journal:  Semin Immunopathol       Date:  2022-03-03       Impact factor: 11.759

4.  Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.

Authors:  Toshifumi Sugatani; Olga A Agapova; Yifu Fang; Alycia G Berman; Joseph M Wallace; Hartmut H Malluche; Marie-Claude Faugere; William Smith; Victoria Sung; Keith A Hruska
Journal:  Kidney Int       Date:  2016-09-22       Impact factor: 10.612

5.  Activated renal tubular Wnt/β-catenin signaling triggers renal inflammation during overload proteinuria.

Authors:  Dickson W L Wong; Wai Han Yiu; Kam Wa Chan; Ye Li; Bin Li; Sarah W Y Lok; Makoto M Taketo; Peter Igarashi; Loretta Y Y Chan; Joseph C K Leung; Kar Neng Lai; Sydney C W Tang
Journal:  Kidney Int       Date:  2018-03-28       Impact factor: 10.612

Review 6.  The role of vasculature in bone development, regeneration and proper systemic functioning.

Authors:  Joanna Filipowska; Krzysztof A Tomaszewski; Łukasz Niedźwiedzki; Jerzy A Walocha; Tadeusz Niedźwiedzki
Journal:  Angiogenesis       Date:  2017-02-13       Impact factor: 9.596

7.  Oxidation-specific epitopes restrain bone formation.

Authors:  Elena Ambrogini; Xuchu Que; Shuling Wang; Fumihiro Yamaguchi; Robert S Weinstein; Sotirios Tsimikas; Stavros C Manolagas; Joseph L Witztum; Robert L Jilka
Journal:  Nat Commun       Date:  2018-06-06       Impact factor: 14.919

8.  oxLDL inhibits differentiation and functional activity of osteoclasts via scavenger receptor-A mediated autophagy and cathepsin K secretion.

Authors:  Damilola Dawodu; Margret Patecki; Jan Hegermann; Inna Dumler; Hermann Haller; Yulia Kiyan
Journal:  Sci Rep       Date:  2018-08-02       Impact factor: 4.379

Review 9.  Dual Effects of Lipid Metabolism on Osteoblast Function.

Authors:  Nathalie S Alekos; Megan C Moorer; Ryan C Riddle
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-23       Impact factor: 5.555

10.  Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice.

Authors:  Michela Palmieri; Maria Almeida; Intawat Nookaew; Horacio Gomez-Acevedo; Teenamol E Joseph; Xuchu Que; Sotirios Tsimikas; Xiaoli Sun; Stavros C Manolagas; Joseph L Witztum; Elena Ambrogini
Journal:  Aging Cell       Date:  2021-07-19       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.